赛科希德分析师会议-2025-03-13

Investment Rating - The report does not explicitly state an investment rating for the medical device industry or the specific company being analyzed [1]. Core Insights - The company specializes in the development, production, and sales of diagnostic instruments, reagents, and consumables in the field of thrombosis and hemostasis [17][18]. - The company employs a business model focused on "independent research and development, production based on sales, and distribution as the main channel" [17]. - The company aims to maintain its competitive advantage in the thrombosis and hemostasis diagnostics market and seeks to replace imported products in the domestic market [18][19]. Summary by Sections 1. Basic Research Information - The research was conducted on March 11, 2025, focusing on the medical device industry, specifically the company Seiko Heid [13]. 2. Detailed Research Institutions - Various institutions participated in the research, including Guotai Junan Securities, Beijing Wantong Zhiyue, and others [14]. 3. Research Institution Proportions - The report does not provide specific data on the proportions of research institutions involved [15]. 4. Main Content Information - The company is a leading domestic manufacturer in the field of thrombosis and hemostasis diagnostics, providing automated testing instruments and related consumables [17]. - The company’s products cover major testing projects in the thrombosis and hemostasis diagnostics field, meeting the primary testing needs of end medical institutions [17]. - The company is focused on extending its product lines in coagulation instruments and reagents while enhancing its service capabilities to increase market share [18][19].